0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Pharmacokinetics Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-8Y2016
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmacokinetics Services Market Insights and Forecast to 2028
BUY CHAPTERS

Pharmacokinetics Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-8Y2016
Report
September 2024
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmacokinetics Services - Market Size

The global market for Pharmacokinetics Services was estimated to be worth US$ 622.2 million in 2023 and is forecast to a readjusted size of US$ 884.8 million by 2030 with a CAGR of 4.7% during the forecast period 2024-2030

Pharmacokinetics Services - Market

Pharmacokinetics Services - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pharmacokinetics Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharmacokinetics Services by region & country, by Type, and by Application.
The Pharmacokinetics Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacokinetics Services.
Market Segmentation

Scope of Pharmacokinetics Services - Market Report

Report Metric Details
Report Name Pharmacokinetics Services - Market
Forecasted market size in 2030 US$ 884.8 million
CAGR 4.7%
Forecasted years 2024 - 2030
Segment by Type:
  • Small Molecules Pharmacokinetics Services
  • Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
Segment by Application
  • Small & Medium Enterprise
  • Large Enterprise
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Evotec AG (Germany), Pacific BioLabs (US), GVK Biosciences Private Limited (India), Shanghai Medicilon Inc. (China), Pharmaceutical Product Development, LLC (US), Charles River Laboratories International, Inc. (US), PAREXEL International Corporation (US), Eurofins Scientific, Inc. (Luxembourg), Frontage Labs (US), SGS SA (Switzerland), LGC Limited (UK), Creative Bioarray (US), Certara, L.P. (Germany)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Pharmacokinetics Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Pharmacokinetics Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Pharmacokinetics Services in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Pharmacokinetics Services - Market size in 2030?

Ans: The Pharmacokinetics Services - Market size in 2030 will be US$ 884.8 million.

Who are the main players in the Pharmacokinetics Services - Market report?

Ans: The main players in the Pharmacokinetics Services - Market are Evotec AG (Germany), Pacific BioLabs (US), GVK Biosciences Private Limited (India), Shanghai Medicilon Inc. (China), Pharmaceutical Product Development, LLC (US), Charles River Laboratories International, Inc. (US), PAREXEL International Corporation (US), Eurofins Scientific, Inc. (Luxembourg), Frontage Labs (US), SGS SA (Switzerland), LGC Limited (UK), Creative Bioarray (US), Certara, L.P. (Germany)

What are the Application segmentation covered in the Pharmacokinetics Services - Market report?

Ans: The Applications covered in the Pharmacokinetics Services - Market report are Small & Medium Enterprise, Large Enterprise

What are the Type segmentation covered in the Pharmacokinetics Services - Market report?

Ans: The Types covered in the Pharmacokinetics Services - Market report are Small Molecules Pharmacokinetics Services, Large Molecules (Biopharmaceuticals) Pharmacokinetics Services

1 Market Overview
1.1 Pharmacokinetics Services Product Introduction
1.2 Global Pharmacokinetics Services Market Size Forecast
1.3 Pharmacokinetics Services Market Trends & Drivers
1.3.1 Pharmacokinetics Services Industry Trends
1.3.2 Pharmacokinetics Services Market Drivers & Opportunity
1.3.3 Pharmacokinetics Services Market Challenges
1.3.4 Pharmacokinetics Services Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmacokinetics Services Players Revenue Ranking (2023)
2.2 Global Pharmacokinetics Services Revenue by Company (2019-2024)
2.3 Key Companies Pharmacokinetics Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Pharmacokinetics Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Pharmacokinetics Services
2.6 Pharmacokinetics Services Market Competitive Analysis
2.6.1 Pharmacokinetics Services Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Pharmacokinetics Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacokinetics Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Small Molecules Pharmacokinetics Services
3.1.2 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
3.2 Global Pharmacokinetics Services Sales Value by Type
3.2.1 Global Pharmacokinetics Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pharmacokinetics Services Sales Value, by Type (2019-2030)
3.2.3 Global Pharmacokinetics Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Small & Medium Enterprise
4.1.2 Large Enterprise
4.2 Global Pharmacokinetics Services Sales Value by Application
4.2.1 Global Pharmacokinetics Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Pharmacokinetics Services Sales Value, by Application (2019-2030)
4.2.3 Global Pharmacokinetics Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Pharmacokinetics Services Sales Value by Region
5.1.1 Global Pharmacokinetics Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pharmacokinetics Services Sales Value by Region (2019-2024)
5.1.3 Global Pharmacokinetics Services Sales Value by Region (2025-2030)
5.1.4 Global Pharmacokinetics Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Pharmacokinetics Services Sales Value, 2019-2030
5.2.2 North America Pharmacokinetics Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Pharmacokinetics Services Sales Value, 2019-2030
5.3.2 Europe Pharmacokinetics Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Pharmacokinetics Services Sales Value, 2019-2030
5.4.2 Asia Pacific Pharmacokinetics Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Pharmacokinetics Services Sales Value, 2019-2030
5.5.2 South America Pharmacokinetics Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Pharmacokinetics Services Sales Value, 2019-2030
5.6.2 Middle East & Africa Pharmacokinetics Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmacokinetics Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pharmacokinetics Services Sales Value
6.3 United States
6.3.1 United States Pharmacokinetics Services Sales Value, 2019-2030
6.3.2 United States Pharmacokinetics Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pharmacokinetics Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pharmacokinetics Services Sales Value, 2019-2030
6.4.2 Europe Pharmacokinetics Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pharmacokinetics Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Pharmacokinetics Services Sales Value, 2019-2030
6.5.2 China Pharmacokinetics Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pharmacokinetics Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pharmacokinetics Services Sales Value, 2019-2030
6.6.2 Japan Pharmacokinetics Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pharmacokinetics Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pharmacokinetics Services Sales Value, 2019-2030
6.7.2 South Korea Pharmacokinetics Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pharmacokinetics Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmacokinetics Services Sales Value, 2019-2030
6.8.2 Southeast Asia Pharmacokinetics Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pharmacokinetics Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Pharmacokinetics Services Sales Value, 2019-2030
6.9.2 India Pharmacokinetics Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pharmacokinetics Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Evotec AG (Germany)
7.1.1 Evotec AG (Germany) Profile
7.1.2 Evotec AG (Germany) Main Business
7.1.3 Evotec AG (Germany) Pharmacokinetics Services Products, Services and Solutions
7.1.4 Evotec AG (Germany) Pharmacokinetics Services Revenue (US$ Million) & (2019-2024)
7.1.5 Evotec AG (Germany) Recent Developments
7.2 Pacific BioLabs (US)
7.2.1 Pacific BioLabs (US) Profile
7.2.2 Pacific BioLabs (US) Main Business
7.2.3 Pacific BioLabs (US) Pharmacokinetics Services Products, Services and Solutions
7.2.4 Pacific BioLabs (US) Pharmacokinetics Services Revenue (US$ Million) & (2019-2024)
7.2.5 Pacific BioLabs (US) Recent Developments
7.3 GVK Biosciences Private Limited (India)
7.3.1 GVK Biosciences Private Limited (India) Profile
7.3.2 GVK Biosciences Private Limited (India) Main Business
7.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Products, Services and Solutions
7.3.4 GVK Biosciences Private Limited (India) Pharmacokinetics Services Revenue (US$ Million) & (2019-2024)
7.3.5 Shanghai Medicilon Inc. (China) Recent Developments
7.4 Shanghai Medicilon Inc. (China)
7.4.1 Shanghai Medicilon Inc. (China) Profile
7.4.2 Shanghai Medicilon Inc. (China) Main Business
7.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Products, Services and Solutions
7.4.4 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Revenue (US$ Million) & (2019-2024)
7.4.5 Shanghai Medicilon Inc. (China) Recent Developments
7.5 Pharmaceutical Product Development, LLC (US)
7.5.1 Pharmaceutical Product Development, LLC (US) Profile
7.5.2 Pharmaceutical Product Development, LLC (US) Main Business
7.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Products, Services and Solutions
7.5.4 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Revenue (US$ Million) & (2019-2024)
7.5.5 Pharmaceutical Product Development, LLC (US) Recent Developments
7.6 Charles River Laboratories International, Inc. (US)
7.6.1 Charles River Laboratories International, Inc. (US) Profile
7.6.2 Charles River Laboratories International, Inc. (US) Main Business
7.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Products, Services and Solutions
7.6.4 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Revenue (US$ Million) & (2019-2024)
7.6.5 Charles River Laboratories International, Inc. (US) Recent Developments
7.7 PAREXEL International Corporation (US)
7.7.1 PAREXEL International Corporation (US) Profile
7.7.2 PAREXEL International Corporation (US) Main Business
7.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Products, Services and Solutions
7.7.4 PAREXEL International Corporation (US) Pharmacokinetics Services Revenue (US$ Million) & (2019-2024)
7.7.5 PAREXEL International Corporation (US) Recent Developments
7.8 Eurofins Scientific, Inc. (Luxembourg)
7.8.1 Eurofins Scientific, Inc. (Luxembourg) Profile
7.8.2 Eurofins Scientific, Inc. (Luxembourg) Main Business
7.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Products, Services and Solutions
7.8.4 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Revenue (US$ Million) & (2019-2024)
7.8.5 Eurofins Scientific, Inc. (Luxembourg) Recent Developments
7.9 Frontage Labs (US)
7.9.1 Frontage Labs (US) Profile
7.9.2 Frontage Labs (US) Main Business
7.9.3 Frontage Labs (US) Pharmacokinetics Services Products, Services and Solutions
7.9.4 Frontage Labs (US) Pharmacokinetics Services Revenue (US$ Million) & (2019-2024)
7.9.5 Frontage Labs (US) Recent Developments
7.10 SGS SA (Switzerland)
7.10.1 SGS SA (Switzerland) Profile
7.10.2 SGS SA (Switzerland) Main Business
7.10.3 SGS SA (Switzerland) Pharmacokinetics Services Products, Services and Solutions
7.10.4 SGS SA (Switzerland) Pharmacokinetics Services Revenue (US$ Million) & (2019-2024)
7.10.5 SGS SA (Switzerland) Recent Developments
7.11 LGC Limited (UK)
7.11.1 LGC Limited (UK) Profile
7.11.2 LGC Limited (UK) Main Business
7.11.3 LGC Limited (UK) Pharmacokinetics Services Products, Services and Solutions
7.11.4 LGC Limited (UK) Pharmacokinetics Services Revenue (US$ Million) & (2019-2024)
7.11.5 LGC Limited (UK) Recent Developments
7.12 Creative Bioarray (US)
7.12.1 Creative Bioarray (US) Profile
7.12.2 Creative Bioarray (US) Main Business
7.12.3 Creative Bioarray (US) Pharmacokinetics Services Products, Services and Solutions
7.12.4 Creative Bioarray (US) Pharmacokinetics Services Revenue (US$ Million) & (2019-2024)
7.12.5 Creative Bioarray (US) Recent Developments
7.13 Certara, L.P. (Germany)
7.13.1 Certara, L.P. (Germany) Profile
7.13.2 Certara, L.P. (Germany) Main Business
7.13.3 Certara, L.P. (Germany) Pharmacokinetics Services Products, Services and Solutions
7.13.4 Certara, L.P. (Germany) Pharmacokinetics Services Revenue (US$ Million) & (2019-2024)
7.13.5 Certara, L.P. (Germany) Recent Developments
8 Industry Chain Analysis
8.1 Pharmacokinetics Services Industrial Chain
8.2 Pharmacokinetics Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pharmacokinetics Services Sales Model
8.5.2 Sales Channel
8.5.3 Pharmacokinetics Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Pharmacokinetics Services Market Trends
    Table 2. Pharmacokinetics Services Market Drivers & Opportunity
    Table 3. Pharmacokinetics Services Market Challenges
    Table 4. Pharmacokinetics Services Market Restraints
    Table 5. Global Pharmacokinetics Services Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Pharmacokinetics Services Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Pharmacokinetics Services Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Pharmacokinetics Services Product Type
    Table 9. Key Companies Time to Begin Mass Production of Pharmacokinetics Services
    Table 10. Global Pharmacokinetics Services Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacokinetics Services as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Pharmacokinetics Services Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Pharmacokinetics Services Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Pharmacokinetics Services Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Pharmacokinetics Services Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Pharmacokinetics Services Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Pharmacokinetics Services Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Pharmacokinetics Services Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Pharmacokinetics Services Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Pharmacokinetics Services Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Pharmacokinetics Services Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Pharmacokinetics Services Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Pharmacokinetics Services Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Pharmacokinetics Services Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Pharmacokinetics Services Sales Value by Region (2019-2024) & (%)
    Table 27. Global Pharmacokinetics Services Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Pharmacokinetics Services Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Pharmacokinetics Services Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Pharmacokinetics Services Sales Value, (2025-2030) & (US$ Million)
    Table 31. Evotec AG (Germany) Basic Information List
    Table 32. Evotec AG (Germany) Description and Business Overview
    Table 33. Evotec AG (Germany) Pharmacokinetics Services Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Pharmacokinetics Services Business of Evotec AG (Germany) (2019-2024)
    Table 35. Evotec AG (Germany) Recent Developments
    Table 36. Pacific BioLabs (US) Basic Information List
    Table 37. Pacific BioLabs (US) Description and Business Overview
    Table 38. Pacific BioLabs (US) Pharmacokinetics Services Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Pharmacokinetics Services Business of Pacific BioLabs (US) (2019-2024)
    Table 40. Pacific BioLabs (US) Recent Developments
    Table 41. GVK Biosciences Private Limited (India) Basic Information List
    Table 42. GVK Biosciences Private Limited (India) Description and Business Overview
    Table 43. GVK Biosciences Private Limited (India) Pharmacokinetics Services Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Pharmacokinetics Services Business of GVK Biosciences Private Limited (India) (2019-2024)
    Table 45. GVK Biosciences Private Limited (India) Recent Developments
    Table 46. Shanghai Medicilon Inc. (China) Basic Information List
    Table 47. Shanghai Medicilon Inc. (China) Description and Business Overview
    Table 48. Shanghai Medicilon Inc. (China) Pharmacokinetics Services Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Pharmacokinetics Services Business of Shanghai Medicilon Inc. (China) (2019-2024)
    Table 50. Shanghai Medicilon Inc. (China) Recent Developments
    Table 51. Pharmaceutical Product Development, LLC (US) Basic Information List
    Table 52. Pharmaceutical Product Development, LLC (US) Description and Business Overview
    Table 53. Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Pharmacokinetics Services Business of Pharmaceutical Product Development, LLC (US) (2019-2024)
    Table 55. Pharmaceutical Product Development, LLC (US) Recent Developments
    Table 56. Charles River Laboratories International, Inc. (US) Basic Information List
    Table 57. Charles River Laboratories International, Inc. (US) Description and Business Overview
    Table 58. Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Pharmacokinetics Services Business of Charles River Laboratories International, Inc. (US) (2019-2024)
    Table 60. Charles River Laboratories International, Inc. (US) Recent Developments
    Table 61. PAREXEL International Corporation (US) Basic Information List
    Table 62. PAREXEL International Corporation (US) Description and Business Overview
    Table 63. PAREXEL International Corporation (US) Pharmacokinetics Services Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Pharmacokinetics Services Business of PAREXEL International Corporation (US) (2019-2024)
    Table 65. PAREXEL International Corporation (US) Recent Developments
    Table 66. Eurofins Scientific, Inc. (Luxembourg) Basic Information List
    Table 67. Eurofins Scientific, Inc. (Luxembourg) Description and Business Overview
    Table 68. Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Pharmacokinetics Services Business of Eurofins Scientific, Inc. (Luxembourg) (2019-2024)
    Table 70. Eurofins Scientific, Inc. (Luxembourg) Recent Developments
    Table 71. Frontage Labs (US) Basic Information List
    Table 72. Frontage Labs (US) Description and Business Overview
    Table 73. Frontage Labs (US) Pharmacokinetics Services Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Pharmacokinetics Services Business of Frontage Labs (US) (2019-2024)
    Table 75. Frontage Labs (US) Recent Developments
    Table 76. SGS SA (Switzerland) Basic Information List
    Table 77. SGS SA (Switzerland) Description and Business Overview
    Table 78. SGS SA (Switzerland) Pharmacokinetics Services Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Pharmacokinetics Services Business of SGS SA (Switzerland) (2019-2024)
    Table 80. SGS SA (Switzerland) Recent Developments
    Table 81. LGC Limited (UK) Basic Information List
    Table 82. LGC Limited (UK) Description and Business Overview
    Table 83. LGC Limited (UK) Pharmacokinetics Services Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Pharmacokinetics Services Business of LGC Limited (UK) (2019-2024)
    Table 85. LGC Limited (UK) Recent Developments
    Table 86. Creative Bioarray (US) Basic Information List
    Table 87. Creative Bioarray (US) Description and Business Overview
    Table 88. Creative Bioarray (US) Pharmacokinetics Services Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Pharmacokinetics Services Business of Creative Bioarray (US) (2019-2024)
    Table 90. Creative Bioarray (US) Recent Developments
    Table 91. Certara, L.P. (Germany) Basic Information List
    Table 92. Certara, L.P. (Germany) Description and Business Overview
    Table 93. Certara, L.P. (Germany) Pharmacokinetics Services Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Pharmacokinetics Services Business of Certara, L.P. (Germany) (2019-2024)
    Table 95. Certara, L.P. (Germany) Recent Developments
    Table 96. Key Raw Materials Lists
    Table 97. Raw Materials Key Suppliers Lists
    Table 98. Pharmacokinetics Services Downstream Customers
    Table 99. Pharmacokinetics Services Distributors List
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
    Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Pharmacokinetics Services Product Picture
    Figure 2. Global Pharmacokinetics Services Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Pharmacokinetics Services Sales Value (2019-2030) & (US$ Million)
    Figure 4. Pharmacokinetics Services Report Years Considered
    Figure 5. Global Pharmacokinetics Services Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Pharmacokinetics Services Revenue in 2023
    Figure 7. Pharmacokinetics Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Small Molecules Pharmacokinetics Services Picture
    Figure 9. Large Molecules (Biopharmaceuticals) Pharmacokinetics Services Picture
    Figure 10. Global Pharmacokinetics Services Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Pharmacokinetics Services Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Small & Medium Enterprise
    Figure 13. Product Picture of Large Enterprise
    Figure 14. Global Pharmacokinetics Services Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Pharmacokinetics Services Sales Value Market Share by Application, 2023 & 2030
    Figure 16. North America Pharmacokinetics Services Sales Value (2019-2030) & (US$ Million)
    Figure 17. North America Pharmacokinetics Services Sales Value by Country (%), 2023 VS 2030
    Figure 18. Europe Pharmacokinetics Services Sales Value (2019-2030) & (US$ Million)
    Figure 19. Europe Pharmacokinetics Services Sales Value by Country (%), 2023 VS 2030
    Figure 20. Asia Pacific Pharmacokinetics Services Sales Value (2019-2030) & (US$ Million)
    Figure 21. Asia Pacific Pharmacokinetics Services Sales Value by Country (%), 2023 VS 2030
    Figure 22. South America Pharmacokinetics Services Sales Value (2019-2030) & (US$ Million)
    Figure 23. South America Pharmacokinetics Services Sales Value by Country (%), 2023 VS 2030
    Figure 24. Middle East & Africa Pharmacokinetics Services Sales Value (2019-2030) & (US$ Million)
    Figure 25. Middle East & Africa Pharmacokinetics Services Sales Value by Country (%), 2023 VS 2030
    Figure 26. Key Countries/Regions Pharmacokinetics Services Sales Value (%), (2019-2030)
    Figure 27. United States Pharmacokinetics Services Sales Value, (2019-2030) & (US$ Million)
    Figure 28. United States Pharmacokinetics Services Sales Value by Type (%), 2023 VS 2030
    Figure 29. United States Pharmacokinetics Services Sales Value by Application (%), 2023 VS 2030
    Figure 30. Europe Pharmacokinetics Services Sales Value, (2019-2030) & (US$ Million)
    Figure 31. Europe Pharmacokinetics Services Sales Value by Type (%), 2023 VS 2030
    Figure 32. Europe Pharmacokinetics Services Sales Value by Application (%), 2023 VS 2030
    Figure 33. China Pharmacokinetics Services Sales Value, (2019-2030) & (US$ Million)
    Figure 34. China Pharmacokinetics Services Sales Value by Type (%), 2023 VS 2030
    Figure 35. China Pharmacokinetics Services Sales Value by Application (%), 2023 VS 2030
    Figure 36. Japan Pharmacokinetics Services Sales Value, (2019-2030) & (US$ Million)
    Figure 37. Japan Pharmacokinetics Services Sales Value by Type (%), 2023 VS 2030
    Figure 38. Japan Pharmacokinetics Services Sales Value by Application (%), 2023 VS 2030
    Figure 39. South Korea Pharmacokinetics Services Sales Value, (2019-2030) & (US$ Million)
    Figure 40. South Korea Pharmacokinetics Services Sales Value by Type (%), 2023 VS 2030
    Figure 41. South Korea Pharmacokinetics Services Sales Value by Application (%), 2023 VS 2030
    Figure 42. Southeast Asia Pharmacokinetics Services Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Pharmacokinetics Services Sales Value by Type (%), 2023 VS 2030
    Figure 44. Southeast Asia Pharmacokinetics Services Sales Value by Application (%), 2023 VS 2030
    Figure 45. India Pharmacokinetics Services Sales Value, (2019-2030) & (US$ Million)
    Figure 46. India Pharmacokinetics Services Sales Value by Type (%), 2023 VS 2030
    Figure 47. India Pharmacokinetics Services Sales Value by Application (%), 2023 VS 2030
    Figure 48. Pharmacokinetics Services Industrial Chain
    Figure 49. Pharmacokinetics Services Manufacturing Cost Structure
    Figure 50. Channels of Distribution (Direct Sales, and Distribution)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

OSZAR »